MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MRX-I is as safe and effective as Linezolid
in the treatment of adult patients with acute bacterial skin and skin structure infections